CompletedPhase 2NCT04120116
FX-322 in Adults With Stable Sensorineural Hearing Loss
Studying Sudden sensorineural hearing loss
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Frequency Therapeutics
- Principal Investigator
- Carl LeBel, PhDFrequency Therapeutics
- Intervention
- FX-322 (One Dose)(drug)
- Enrollment
- 95 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2019 – 2020
Study locations (15)
- Clinical Trial Site, Fresno, California, United States
- Clinical Trial Site, Torrance, California, United States
- Clinical Trial Site, Colorado Springs, Colorado, United States
- Clinical Trial Site, Boca Raton, Florida, United States
- Clinical Trial Site, Sarasota, Florida, United States
- Clinical Trial Site, Tampa, Florida, United States
- Clinical Trial Site, Louisville, Kentucky, United States
- Clinical Trial Site, Omaha, Nebraska, United States
- Clinical Trial Site, Amherst, New York, United States
- Clinical Trial Site, Matthews, North Carolina, United States
- Clinical Trial Site, Winston-Salem, North Carolina, United States
- Clinical Trial Site, Orangeburg, South Carolina, United States
- Clinical Trial Site, Austin, Texas, United States
- Clinical Trial Site, San Antonio, Texas, United States
- Clinical Trial Site, Richmond, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04120116 on ClinicalTrials.govOther trials for Sudden sensorineural hearing loss
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONEARLY PHASE1NCT07472023Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing LossTruway Health, Inc.
- ACTIVE NOT RECRUITINGNANCT07045883Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing LossZhongshan Hospital Xiamen University
- RECRUITINGPHASE4NCT06968507Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing LossDr. Lutfi Kirdar Kartal Training and Research Hospital
- ENROLLING BY INVITATIONNCT06355102The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and MetabolomicsThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE1, PHASE2NCT06249919A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL PatientsNeuracle Science Co., LTD.
- RECRUITINGPHASE4NCT04826237Oral Statins and Protection From Hearing LossNorthwestern University
- ACTIVE NOT RECRUITINGPHASE2NCT05776459Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)AudioCure Pharma GmbH
- RECRUITINGNCT05474963Sudden Sensorineural Hearing Loss in Wonju Severance Christian HospitalWonju Severance Christian Hospital